Project Grant HT94252310946
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$498K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, a $1,467,210 Project Grant on September 30, 2024. The grant supports research to develop a novel dendritic cell therapy approach for mucosal melanoma, focusing on targeting a differentiation epitope in CD11b of tumor-associated inflammatory monocytes. The research aims...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...
The Department of the Army Medical Command awarded Case Western Reserve University a $1,288,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to therapeutically target superclusters at genes driving childhood sarcoma from September 2021 through September 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,163,218.00 to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) to conduct research on SLC37A3 as a novel prostate cancer target. The award period runs from July 15, 2024 to July 14, 2028. Through this funding, Case Western Reserve University will carry out...
The Department of Defense's Defense Health Agency awarded a $9,870,517 Project Grant to Case Western Reserve University to conduct a pilot randomized controlled trial of the ISENS system for sensorimotor restoration after limb loss. The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund this research initiative from July 1, 2025 through June 30, 2029. As a leading private research university, Case Western Reserve University will leverage its...
This Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program provides $3,908,980.00 to Case Western Reserve University (CWRU) to enhance walking and independence for individuals with incomplete spinal cord injuries (SCI) through the development and implementation of a fully implanted neuroprosthetic system. The 4-year award, which commenced on September 15, 2024, supports CWRU's efforts to advance this innovative...
The U.S. Defense Health Agency awarded a $488,198 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation to support the development and evaluation of agents for a poor prognostic vertebrate model of Ewing sarcoma. The grant term runs from September 1, 2024 to August 31, 2027. As a sub-award under this grant, Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Defense Health Agency awarded a $1,249,009 Project Grant to the Research Institute at Nationwide Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 15, 2023, funds a 4-year project titled "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA" to conduct medical research and development related to improving treatments for glioma, a type of brain cancer. As a non-profit research institute, the...